NovoCure Ltd. (NVCR)
17.89
+1.06
(+6.30%)
USD |
NASDAQ |
May 08, 16:00
17.96
+0.07
(+0.39%)
After-Hours: 20:00
NovoCure EPS Diluted (Quarterly) : -0.6232 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| LivaNova Plc | 0.3985 |
| AtriCure, Inc. | 0.0022 |
| LeMaitre Vascular, Inc. | 0.6808 |
| Globus Medical, Inc. | 0.8995 |
| Glaukos Corp. | -0.341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -71.14M |
| Revenue (Quarterly) | 174.06M |
| Total Expenses (Quarterly) | 245.19M |
| Enterprise Value | 1.865B |
| Gross Profit Margin (Quarterly) | 77.63% |
| Profit Margin (Quarterly) | -40.87% |
| Earnings Yield | -8.58% |
| Normalized Earnings Yield | -8.576 |